The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

Michael Brambley, a mechanical engineer at PNNL, receives ASHRAE Exceptional Service Award.

Srinivas Katipamula, a staff scientist at PNNL, has been honored with an ASHRAE Exceptional Service Award.

A new control system shows promise in making millions of homes contributors to improved power grid operations, reaping cost and environmental benefits.

Researchers use machine learning to speed up the analysis of aerosol datasets from mass spectrometry.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

Data from increasingly complex mass spectrometry instruments met with adaptable data analysis solution.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Applying new approaches in energy codes may support improved building efficiency and decarbonization in the Big Apple and beyond.

Mowei Zhou, a chemist with the Environmental Molecular Sciences Laboratory, is speaking at the ACS spring conference on his latest protein discoveries for a plant that could transform biofuels production.

Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

Next generation triple-pane windows provide builders with lower cost options and help homeowners conserve energy, reduce noise, and lower home energy bills.

PNNL will provide technical resources and support to a national coalition of states and cities focused on implementing building performance standards to improve energy efficiency and reduce carbon emissions.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

In adjoining Energy Sciences Center laboratories, researchers develop better energy storage devices by understanding the fundamental reactions that form interfaces.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.